Canaccord Genuity initiated coverage on DICE Therapeutics with a new price target

5/22/23 7:17:25 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Canaccord Genuity initiated coverage of DICE Therapeutics with a rating of Buy and set a new price target of $71.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DICE

Date	Price Target	Rating	Analyst
5/24/2023	$38.00	Equal Weight	Wells Fargo
5/22/2023	$71.00	Buy	Canaccord Genuity
3/31/2023	$56.00	Buy	Needham
3/1/2023		Outperform	TD Cowen
3/1/2023		Outperform	Cowen
11/15/2022	$65.00	Buy	Guggenheim
9/14/2022	$36.00	Overweight	Cantor Fitzgerald
9/7/2022	$37.00	Buy	Stifel